UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000029845 |
|---|---|
| Receipt number | R000034092 |
| Scientific Title | Feasibility study of bilateral salpingo-oophorectomy for pre-menopausal patients with metastatic luminal-type breast cancer |
| Date of disclosure of the study information | 2017/12/01 |
| Last modified on | 2019/02/04 15:34:33 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Feasibility study of bilateral salpingo-oophorectomy for pre-menopausal patients with metastatic luminal-type breast cancer
Acronym
Feasibility study of bilateral salpingo-oophorectomy for pre-menopausal patients with metastatic luminal-type breast cancer
Scientific Title
Feasibility study of bilateral salpingo-oophorectomy for pre-menopausal patients with metastatic luminal-type breast cancer
Scientific Title:Acronym
Feasibility study of bilateral salpingo-oophorectomy for pre-menopausal patients with metastatic luminal-type breast cancer
Region
| Japan |
Condition
Condition
Breast Cancer
Classification by specialty
| Breast surgery | Obstetrics and Gynecology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
1. To evaluate safety of the surgery
2. To evaluate adverse events after the surgery
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
1. Adverse events during the surgery
2. Adverse events after the surgery
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
Bilateral salpingo-oophorectomy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Female
Key inclusion criteria
1. pathologically proven breast cancer
2. pre-menopaose before starting treatment
3. recurrent or metastatic breast cancer
4. ER/PgR positive breast cancer
5. plan for endocrine treatment
6. ECOG Performance Status 0-1
7. no major organ disfunction
8. life expectancy > 6 months
9. understanding the sugery will not covered by insurance
10. informed consent
Key exclusion criteria
1. pregnant or lactation
2. other reasons by which researchers decide that the patient is not suitable for this study
Target sample size
25
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masakazu Toi |
Organization
Graduate School of Medicine, Kyoto University
Division name
Breast Surgery
Zip code
Address
54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, Japan
TEL
075-751-3660
toi@kuhp.kyoto-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Masahiro Takada |
Organization
Graduate School of Medicine, Kyoto University
Division name
Breast Surgery
Zip code
Address
54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, Japan
TEL
075-751-3111
Homepage URL
masahiro@kuhp.kyoto-u.ac.jp
Sponsor or person
Institute
Kyoto University Hospital
Institute
Department
Personal name
Funding Source
Organization
Kyoto University Hospital
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 12 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2017 | Year | 11 | Month | 06 | Day |
Date of IRB
Anticipated trial start date
| 2018 | Year | 04 | Month | 09 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 11 | Month | 06 | Day |
Last modified on
| 2019 | Year | 02 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034092
